A study by Cleveland Clinic and USC researchers long-term risk associated with COVID-19 “continues to pose a significant ...

A study published in the American Journal of Obstetrics and Gynecology demonstrates that when the diabetes drug metformin is ...

A new long COVID study could be a “game changer,” according to local researchers who found that an AI tool can identify ...

That tends to mask the fact that she got COVID-19 three years ago — and never got better. The 34-year-old Overland Park ...

About $1.6 billion has been invested in research that has yielded little progress, disappointing many who suffer with the ...

But those kinds of risk factors aren’t enough on their own. People have to be exposed to one or more “triggers” that tip the ...

Of the 3,544 deaths related to long COVID in the US up to June 2022, the most commonly recorded underlying cause was COVID ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

COVID-19 will continue to spread at different levels in our communities, and outbreaks will still occur. New variants of concern may also emerge. There's also uncertainty around how long immunity from ...

New research suggests that using the diabetes drug metformin for COVID-19 could help lower the risk of long Covid symptoms and improve its recovery time by as much as 41%, according to data presented ...